Equities

Aoti Inc

AOTI:LSE

Aoti Inc

Actions
Health CareMedical Equipment and Services
  • Price (GBX)129.00
  • Today's Change0.00 / 0.00%
  • Shares traded10.00k
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Nov 20 2024 09:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Aoti, Inc. is engaged in wound care technology around the world. The Company is focused on helping all people with chronic conditions get back to living their lives to the fullest. It does this by enhancing access to care, improving clinical outcomes and quality of life, and advancing health equity. Its products are built with integrity and backed by robust clinical evidence, ensuring safety and efficacy for its patients. Its solutions include Topical Wound Oxygen (TWO2) and NEXA Negative Pressure Wound Therapy (NPWT). TWO2 therapy is a multi-modality patient-administered therapy. TWO2 is a clinically proven therapy for the treatment of chronic and difficult-to-heal wounds. The NEXA NPWT System is a multi-week, multi-patient, disposable system that delivers the performance and flexibility of traditional NPWT systems. TWO2 therapy solutions include TWO2 Extremity Chamber and TWO2 Multi-Patch.

  • Revenue in GBP (TTM)39.26m
  • Net income in GBP-7.44m
  • Incorporated2008
  • Employees80.00
  • Location
    Aoti Inc3512 Seagate Way, Suite 100OCEANSIDE 92056United StatesUSA
  • Phone+1 (760) 431-4700
  • Fax+1 (760) 683-3063
  • Websitehttps://aotinc.net/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Ondine Biomedical Inc929.32k-8.12m33.19m43.00--2,095.79--35.71-0.0368-0.03680.00420.000040.28590.54979.93---249.74---597.99--60.04---873.56--0.4828--0.9487--88.56--25.60------
ANGLE plc2.02m-18.03m35.49m150.00--1.45--17.53-0.0684-0.06840.00770.0760.05530.31171.2113,493.33-49.30---55.77--69.07---890.91--4.80--0.1469--109.99--7.17------
Tissue Regenix Group PLC25.26m-874.78k41.26m76.00--1.731,366.621.63-0.0124-0.01240.35810.33430.70611.336.41332,416.70-2.17-13.45-2.43-14.7849.4845.90-3.08-28.801.470.37160.263--20.5013.7536.44--9.78--
Inspecs Group PLC195.14m-4.11m54.90m1.67k--0.53866.450.2814-0.0404-0.04041.921.000.86672.317.65116,640.80-1.82-1.48-2.62-2.1551.4648.50-2.10-1.970.86960.64410.377--1.1636.4584.22--51.04--
SDI Group PLC65.85m4.23m62.52m503.0014.881.387.590.94950.04020.04020.62560.43440.7930.9895.34130,906.605.127.856.1110.0130.8464.066.469.481.354.850.3210.00-2.5630.469.3017.2212.08--
Creo Medical Group PLC30.30m-22.40m66.46m278.00--1.23--2.19-0.0629-0.06290.08520.13110.38351.853.33105,574.90-28.35-26.07-32.89-30.9449.5047.58-73.93-118.242.38--0.2305--13.36--19.44------
EKF Diagnostics Holdings PLC50.95m4.78m114.34m309.0023.951.6611.442.240.01050.01050.11230.15160.63073.016.99160,728.706.345.207.356.1348.0550.0410.057.913.081,703.500.0175113.68-21.054.34123.28-25.3030.37--
Aoti Inc39.26m-7.44m137.90m80.00--11.32--3.51-0.07-0.070.36910.11451.563.578.18327,156.20-29.55---41.81--85.76---18.96--2.57-3.080.4812--31.06---191.92------
Tristel Plc41.93m6.49m209.77m213.0032.606.4522.815.000.1350.1350.87140.68180.98121.815.74--15.189.3217.7510.7680.0880.7515.4711.093.04--0.1532109.3516.459.8945.469.9910.1319.53
Advanced Medical Solutions Group plc131.11m11.13m445.37m1.50k40.091.8319.833.400.0510.0510.60111.120.39771.704.91154,244.703.386.543.647.0654.4556.758.4914.826.80--0.270225.851.514.23-22.14-6.7115.6612.32
Data as of Nov 20 2024. Currency figures normalised to Aoti Inc's reporting currency: UK Pound GBX

Institutional shareholders

11.74%Per cent of shares held by top holders
HolderShares% Held
Artemis Investment Management LLPas of 31 Jul 20243.79m3.56%
Royal London Asset Management Ltd.as of 31 Jul 20242.42m2.28%
Wasatch Advisors LPas of 30 Sep 20241.80m1.69%
Fondita Fund Management Co. Ltd.as of 30 Sep 20241.14m1.07%
Octopus Investments Ltd.as of 31 Oct 20241.01m0.95%
Premier Fund Managers Ltd.as of 31 Jul 2024878.79k0.83%
Ninety One UK Ltd.as of 31 Jul 2024757.58k0.71%
Cooke & Bieler LPas of 28 Jun 2024401.04k0.38%
Grandeur Peak Global Advisors LLCas of 31 Jul 2024212.35k0.20%
R.C. Brown Investment Management Plcas of 31 Oct 202485.00k0.08%
More ▼
Data from 30 Sep 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.